These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 8208757)
1. 5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine. King GR; Joyner CM; Ellinwood EH Pharmacol Biochem Behav; 1994 Mar; 47(3):399-407. PubMed ID: 8208757 [TBL] [Abstract][Full Text] [Related]
2. Blockade of cocaine sensitization and tolerance by the co-administration of ondansetron, a 5-HT3 receptor antagonist, and cocaine. King GR; Xiong Z; Ellinwood EH Psychopharmacology (Berl); 1997 Mar; 130(2):159-65. PubMed ID: 9106914 [TBL] [Abstract][Full Text] [Related]
3. Blockade of the expression of sensitization and tolerance by ondansetron, a 5-HT3 receptor antagonist, administered during withdrawal from intermittent and continuous cocaine. King GR; Xiong Z; Ellinwood EH Psychopharmacology (Berl); 1998 Feb; 135(3):263-9. PubMed ID: 9498729 [TBL] [Abstract][Full Text] [Related]
4. Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist. King GR; Xiong Z; Douglass S; Ellinwood EH Eur J Pharmacol; 2000 Apr; 394(1):97-101. PubMed ID: 10771040 [TBL] [Abstract][Full Text] [Related]
5. Withdrawal from continuous or intermittent cocaine: effects of NAN-190 on cocaine-induced locomotion. King GR; Joyner C; Lee TH; Ellinwood EH Pharmacol Biochem Behav; 1993 Feb; 44(2):253-62. PubMed ID: 8446658 [TBL] [Abstract][Full Text] [Related]
6. Blockade of accumbens 5-HT3 receptor down-regulation by ondansetron administered during continuous cocaine administration. King GR; Xiong Z; Ellinwood EH Eur J Pharmacol; 1999 Jan; 364(2-3):79-87. PubMed ID: 9932709 [TBL] [Abstract][Full Text] [Related]
7. Continuous or intermittent cocaine administration: effects of amantadine treatment during withdrawal. King GR; Joyner C; Ellinwood EH Pharmacol Biochem Behav; 1994 Mar; 47(3):451-7. PubMed ID: 8208762 [TBL] [Abstract][Full Text] [Related]
8. The effects of continuous 5-HT(3) receptor antagonist administration on the subsequent behavioral response to cocaine. King GR; Pinto G; Konen J; Castro G; Tran S; Hilburn C Eur J Pharmacol; 2002 Aug; 449(3):253-9. PubMed ID: 12167467 [TBL] [Abstract][Full Text] [Related]
9. Continuous or intermittent cocaine administration: effects of flupenthixol treatment during withdrawal. King GR; Joyner C; Ellinwood EH Pharmacol Biochem Behav; 1994 Dec; 49(4):883-9. PubMed ID: 7886102 [TBL] [Abstract][Full Text] [Related]
10. Ondansetron given in the acute withdrawal from a repeated cocaine sensitization dosing regimen reverses the expression of sensitization and inhibits self-administration. Davidson C; Lee TH; Xiong Z; Ellinwood EH Neuropsychopharmacology; 2002 Oct; 27(4):542-53. PubMed ID: 12377391 [TBL] [Abstract][Full Text] [Related]
11. Withdrawal from continuous or intermittent cocaine: behavioral responsivity to 5-HT1 receptor agonists. King GR; Joyner CM; Ellinwood EH Pharmacol Biochem Behav; 1993 Jul; 45(3):577-87. PubMed ID: 8332619 [TBL] [Abstract][Full Text] [Related]
12. Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats. Szumlinski KK; Frys KA; Kalivas PW Psychopharmacology (Berl); 2003 Feb; 165(4):329-36. PubMed ID: 12451437 [TBL] [Abstract][Full Text] [Related]
13. Intermittent and continuous cocaine administration: residual behavioral states during withdrawal. King GR; Joyner C; Lee T; Kuhn C; Ellinwood EH Pharmacol Biochem Behav; 1992 Sep; 43(1):243-8. PubMed ID: 1409810 [TBL] [Abstract][Full Text] [Related]
14. 5-HT3 agonist-induced dopamine overflow during withdrawal from continuous or intermittent cocaine administration. King GR; Xue Z; Calvi C; Ellinwood EH Psychopharmacology (Berl); 1995 Feb; 117(4):458-65. PubMed ID: 7604148 [TBL] [Abstract][Full Text] [Related]
15. Effect of the 5-HT3 receptor antagonist ondansetron on amphetamine-induced hyperactivity and stereotypy in rats. Shankar RP; Karan RS; Handu SS; Bhargava VK Indian J Physiol Pharmacol; 2000 Jul; 44(3):355-8. PubMed ID: 10941627 [TBL] [Abstract][Full Text] [Related]
16. Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats. Neisewander JL; Lucki I; McGonigle P Pharmacol Biochem Behav; 1996 Apr; 53(4):935-42. PubMed ID: 8801600 [TBL] [Abstract][Full Text] [Related]
17. PI3 kinase is involved in cocaine behavioral sensitization and its reversal with brain area specificity. Zhang X; Mi J; Wetsel WC; Davidson C; Xiong X; Chen Q; Ellinwood EH; Lee TH Biochem Biophys Res Commun; 2006 Feb; 340(4):1144-50. PubMed ID: 16414349 [TBL] [Abstract][Full Text] [Related]
18. 5HT3 receptor antagonists do not block nicotine induced hyperactivity in rats. Arnold B; Allison K; Ivanová S; Paetsch PR; Paslawski T; Greenshaw AJ Psychopharmacology (Berl); 1995 May; 119(2):213-21. PubMed ID: 7659769 [TBL] [Abstract][Full Text] [Related]
19. Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats. Neisewander JL; Lucki I; McGonigle P Synapse; 1994 Jan; 16(1):1-10. PubMed ID: 8134896 [TBL] [Abstract][Full Text] [Related]
20. Effects of 5-HT3 receptor-selective agents on locomotor activity in rats following injection into the nucleus accumbens and the ventral tegmental area. Gillies DM; Mylecharane EJ; Jackson DM Eur J Pharmacol; 1996 May; 303(1-2):1-12. PubMed ID: 8804905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]